Lisa Mielniczuk

TL;DR: In this article, a population-based study of the incidence, mortality, and risk factors for peripartum cardiomyopathy (PC) in the United States was conducted.

TL;DR: Treatment approaches continue to evolve, but prevention remains the focus, and newer mammalian target of rapamycin inhibitors can significantly delay the progression of CAV; however, their optimal use remains to be established.

TL;DR: In this paper, the authors provide comprehensive recommendations and practical tips for the pharmacologic management of patients with heart failure with reduced ejection fraction (HFrEF) including angiotensin receptor-neprilysin inhibitors, sinus node inhibitors, sodium glucose transport 2 inhibitors, and soluble guanylate cyclase stimulators.

TL;DR: The results suggest that noninvasive ventilation with standard medical Therapy is advantageous over standard medical therapy alone in ED patients with acute cardiogenic pulmonary edema.

TL;DR: High-dose diuretics may be more of a marker than a cause of instability in chronic heart failure, and a history of HF stability during the past 6 months is associated with an 80% lower risk of an HF event during the next year, independently of baseline diuretic dose.